Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Most Cited: 30 Most Citation Articles
Review | Open Access
Methods for monitoring cancer cell pyroptosis
Published: 01 April 2022
2022, 19 (4): 398-414
Review | Open Access
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Published: 12 January 2023
2023, 20 (1): 25-43
Review | Open Access
Breast cancer screening and early diagnosis in Chinese women
Published: 01 April 2022
2022, 19 (4): 450-467
Original Article | Open Access
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Published: 03 November 2022
2022, 19 (10): 1460-1476
Review | Open Access
Major roles of the circadian clock in cancer
Published: 12 January 2023
2023, 20 (1): 1-24
Review | Open Access
Advances in lung cancer screening and early detection
Published: 24 June 2022
2022, 19 (5): 591-608
Review | Open Access
The advanced development of molecular targeted therapy for hepatocellular carcinoma
Published: 15 June 2022
2022, 19 (6): 802-817
Review | Open Access
Bacterial outer membrane vesicle-based cancer nanovaccines
Published: 22 September 2022
2022, 19 (9): 1290-1300
Review | Open Access
Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
Published: 24 March 2023
2023, 20 (3): 181-195
Review | Open Access
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
Published: 05 December 2022
2022, 19 (11): 1543-1564
Total 30